Great Lakes Advisors, LLC Pfizer Inc Transaction History

Great Lakes Advisors, LLC

$11.1 Billion
Q3 2024

A detailed history of Great Lakes Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Great Lakes Advisors, LLC holds 17,599 shares of PFE stock, worth $455,638. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,599

Previous 18,093 2.73%

Holding current value

$455,638

Previous $506,000 0.59%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$27.7 - $31.39 $13,683 - $15,506	-494 Reduced 2.73%	17,599 $509,000
Q2 2024 Aug 05, 2024	BUY	$25.26 - $29.6 $117,661 - $137,876	4,658 Added 34.67%	18,093 $506,000
Q1 2024 May 08, 2024	SELL	$25.89 - $29.73 $6,006 - $6,897	-232 Reduced 1.7%	13,435 $372,000
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $173,607 - $225,497	-6,644 Reduced 32.71%	13,667 $393,000
Q3 2023 Nov 07, 2023	BUY	$32.09 - $37.51 $202,423 - $236,613	6,308 Added 45.05%	20,311 $673,000
Q2 2023 Aug 10, 2023	SELL	$36.12 - $41.79 $1.25 Million - $1.45 Million	-34,706 Reduced 71.25%	14,003 $513,000
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $50,104 - $65,228	1,272 Added 2.68%	48,709 $1.99 Million
Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $1.12 Million - $1.46 Million	26,809 Added 129.96%	47,437 $2.43 Million
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $63,145 - $77,085	1,443 Added 7.52%	20,628 $903,000
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $111,997 - $132,794	-2,407 Reduced 11.15%	19,185 $1.01 Million
Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $109,983 - $136,282	-2,404 Reduced 10.02%	21,592 $1.12 Million
Q4 2021 Feb 09, 2022	SELL	$41.32 - $61.25 $10,495 - $15,557	-254 Reduced 1.05%	23,996 $1.42 Million
Q3 2021 Nov 09, 2021	BUY	$39.25 - $50.42 $77,008 - $98,924	1,962 Added 8.8%	24,250 $1.04 Million
Q2 2021 Aug 11, 2021	SELL	$35.91 - $40.68 $11,347 - $12,854	-316 Reduced 1.4%	22,288 $873,000
Q1 2021 May 03, 2021	SELL	$33.49 - $37.77 $35,566 - $40,111	-1,062 Reduced 4.49%	22,604 $819,000
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $2,409 - $3,064	72 Added 0.31%	23,666 $871,000
Q3 2020 Nov 04, 2020	BUY	$31.75 - $37.25 $16,287 - $19,109	513 Added 2.22%	23,594 $866,000
Q2 2020 Aug 07, 2020	SELL	$30.12 - $36.54 $40,360 - $48,963	-1,340 Reduced 5.49%	23,081 $755,000
Q1 2020 May 08, 2020	SELL	$27.03 - $38.62 $67,791 - $96,858	-2,508 Reduced 9.31%	24,421 $797,000
Q4 2019 Feb 07, 2020	SELL	$32.92 - $37.36 $1,152 - $1,307	-35 Reduced 0.13%	26,929 $1.06 Million
Q3 2019 Nov 06, 2019	SELL	$32.49 - $42.13 $2.2 Million - $2.86 Million	-67,781 Reduced 71.54%	26,964 $969,000
Q2 2019 Aug 05, 2019	SELL	$36.98 - $41.52 $5.07 Million - $5.69 Million	-137,145 Reduced 59.14%	94,745 $4.11 Million
Q1 2019 May 07, 2019	SELL	$37.5 - $41.2 $5.45 Million - $5.99 Million	-145,320 Reduced 38.52%	231,890 $9.85 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $6.34 Million - $7.23 Million	164,752 Added 77.55%	377,210 $16.5 Million
Q3 2018 Nov 30, 2018	BUY	$34.47 - $41.81 $6.53 Million - $7.92 Million	189,519 Added 826.19%	212,458 $9.36 Million
Q3 2018 Nov 15, 2018	SELL	$34.47 - $41.81 $49,257 - $59,746	-1,429 Reduced 5.86%	22,939 $1.01 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $8,838 - $9,422	-268 Reduced 1.09%	24,368 $884,000
Q1 2018 May 07, 2018	SELL	$31.91 - $37.02 $370,762 - $430,135	-11,619 Reduced 32.05%	24,636 $874,000
Q4 2017 Feb 08, 2018	SELL	$33.26 - $35.29 $478,045 - $507,223	-14,373 Reduced 28.39%	36,255 $1.31 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $1.57 Million - $1.73 Million	50,628	50,628 $1.81 Million

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.

Account

Great Lakes Advisors, LLC Pfizer Inc Transaction History